Article Information
History
- October 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Dennis M. Bierle1,
- Ravindra Ganesh1,
- Sidna Tulledge-Scheitel1,
- Sara N. Hanson2,
- Lori L. Arndt3,
- Caroline G. Wilker4 and
- Raymund R. Razonable1,*
- 1Mayo Clinic, Rochester, MN
- 2Mayo Clinic Health Systems, Mankato, MN
- 3Mayo Clinic Health Systems, Eau Claire, WI
- 4Mayo Clinic Health Systems – Franciscan Healthcare, LaCrosse, WI
- ↵*Correspondence:
Raymund R Razonable, MD, Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, Razonable.raymund{at}mayo.edu
Posted October 20, 2021.
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
